Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pharmacovigilance Feeds EMA’s Transparency Drive

Executive Summary

The scandal surrounding the withdrawal of Servier’s diabetes drug Mediator (benfluorex) continues to rock the French medical establishment, but it also has drawn attention to the issue of regulators' transparency more broadly – including at the European Medicines Agency.

Related Content

French Drug Industry Group Kicked Off Key Gov't Committee
ICH Reforms Will "Professionalize" Harmonization, PhRMA's Rep Says
EMA Leadership Goes To Pott After Rasi Retroactively Unhired
Clinical Trials Transparency: EMA Delay Gives Industry Initiative More Time To Take Root
Europe Transparency Initiatives May Aid Progress Toward Adaptive Licensing Systems
Can Europe's Approval And Value Reviews Work More In Concert? It's A Timesaver That Might Be A Long Time Coming
Improved EU Pharmacovigilance May Not Prevent Another Mediator
Transparency Phase III: FDA Offers Designs For Industry Review
Transparency Phase III: FDA Offers Designs For Industry Review
Where FDA Is Paying The Most Attention: Drug Safety Advisory Committee Had The Most Meetings In 2010





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts